Description
What is Tirzepatide?
Tirzepatide is a synthetic peptide that acts at GIP and GLP-1 receptors. It is studied in incretin-receptor signalling and metabolic research. This research material is not presented as a licensed finished medicinal product.
Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.
Published study findings and evidence limits
Human trial evidence
The SURMOUNT-1 randomised trial reported greater body-weight reduction with tirzepatide than placebo in adults with obesity or overweight and a related complication, without diabetes. Gastrointestinal adverse effects were common. These findings apply to the studied medicinal formulation and population.
Sources: SURMOUNT-1 trial (2022).
Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.
For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.
Reviews
There are no reviews yet.